AI assistant
Sending…
TriSalus Life Sciences, Inc. — Director's Dealing 2026
Feb 23, 2026
33473_dirs_2026-02-23_d76c6476-c70e-46b8-94e9-e8c9d6361bfe.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TriSalus Life Sciences, Inc. (TLSI)
CIK: 0001826667
Period of Report: 2026-02-23
Reporting Person: Valle William (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-02-23 | Common Stock | P | 30487 | $4.10 | Acquired | 30487 | Direct |
More from TriSalus Life Sciences, Inc.
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Regulatory Filings
2026
Apr 29
Regulatory Filings
2026
Apr 7
Director's Dealing
2026
Mar 20
Director's Dealing
2026
Mar 20
Director's Dealing
2026
Mar 20
Director's Dealing
2026
Mar 20
Director's Dealing
2026
Mar 20